More Argent Biopharma Ltd news
Argent Biopharma LtdASX: RGT

MGC pharma launches CannEpil app

Oct 6, 2020 at 10:42 PM EDT · Issued by Argent Biopharma Ltd

Filed with ASX · Oct 6, 2020 at 10:42 PM EDT · 3 pages · English

On 6ix: 6ix.com/news/mgc-pharma-launches-cannepil-app

Argent Biopharma Ltd on 6ix

Story so far

  • Binding Term Sheet for distribution of CannEpil in IsraelJun 15, 2020
  • Ethics Committee Approval for CannEpil Phase IIb TrialMay 26, 2020
  • Approval Received for Distribution of CannEpil into IrelandDec 3, 2019

Earlier from Argent Biopharma

  • Update on ArtemiC phase II trial on COVID-19 patientsSep 28, 2020
  • Mxc welcomes new FCA guidance for cannabis sector in the UKSep 20, 2020
  • Mxc well positioned for tga down-schedule of cbd productsSep 13, 2020
  • $15M finance facility to fund revenue growth for key marketsSep 10, 2020
  • Appendix 4E and Preliminary Unaudited Financial ReportAug 31, 2020

Later from Argent Biopharma

  • First high THC products shipped direct to Brazil patientsOct 11, 2020
  • ArtemiC histology on rats confirm no pathological impactOct 14, 2020
  • Mgc pharma delivers record consecutive weekly sales growthOct 19, 2020
  • September Quarterly Activity and Cashflow ReportOct 26, 2020
  • Completion of phase II clinical trial on COVID-19 patientsNov 4, 2020
All Argent Biopharma news releases↗

Follow Argent Biopharma into a list and get an email when it puts out news.

Follow Argent Biopharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer